[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363626-105":59,"doc-detail-363626-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrative-multi-omics-profiling-reveals-distinct-evolutionary-and-immunogenic-features-of-brain-oligometastasis-in-lung-adenocarcinoma","Integrative multi-omics profiling reveals distinct evolutionary and immunogenic features of brain oligometastasis in lung adenocarcinoma","","Local radical therapy can benefit lung cancer patients with brain oligometastases, but the molecular basis of the oligometastatic phenotype in the central nervous system remains unclear. Using 1021-panel sequencing, transcriptome profiling, DNA methylation mapping, and multiplex immunohistochemistry on 20 paired primary lung adenocarcinoma and oligo-BM specimens, the study delineates evolutionary dynamics and microenvironmental features, including immune suppression and methylation-linked regulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-multi-omics-profiling-reveals-distinct-evolutionary-and-immunogenic-features-of-brain-oligometastasis-in-lung-adenocarcinoma/363626/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-multi-omics-profiling-reveals-distinct-evolutionary-and-immunogenic-features-of-brain-oligometastasis-in-lung-adenocarcinoma/363626.png","ImageObject",300,407,{"name":92,"@type":93},"4398046744996","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical problem does the study address?","Question",{"text":112,"@type":113},"The study addresses how to understand the molecular determinants of the oligometastatic phenotype in the central nervous system, specifically for brain oligometastases in lung adenocarcinoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data and methods were used to analyze the tumors?",{"text":117,"@type":113},"Researchers used 1021-panel sequencing, transcriptome profiling, DNA methylation mapping, and multiplex immunohistochemistry on paired primary and brain oligometastasis specimens.",{"name":119,"@type":110,"acceptedAnswer":120},"What key biological differences were found between primary tumors and oligo-BMs?",{"text":121,"@type":113},"Primary tumors and oligo-BMs showed pronounced intertumor heterogeneity, with conserved intratumoral heterogeneity across lesions, alongside a more immunosuppressed microenvironment in oligo-BMs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363626,1790879556,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":66,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":138,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":26,"preview_page_count":19,"preview_urls":144},4398046744996,"Liao et al. Genome Medicine (2026) 18:82  \n[https://doi.org/10.1186/s13073-026-01664-4](https://doi.org/10.1186/s13073-026-01664-4)  \nGenome Medicine  \nRESEARCH Open Access  \nIntegrative multi-omics profiling reveals distinct evolutionary and immunogenic features of brain oligometastasis in lung adenocarcinoma  \nRongxin Liao1,2†, Qian Yu1,2†, Yusheng Huang1†, Hengqiu He1,2, Mengmeng Song3, Xuan Gao3,6, Lu Shen3, Yihao Tao4, Lin Li5, Gang Xiao7, Rui Kong1,10, Cancan Wang11, Shunping Huang1,2, Xiaoyue Zhang1,2, Zaicheng Xu1,2, Rongrong Zhou7,8,9*, Zhenzhou Yang1,2* and Yuan Peng1,2*†  \nAbstract  \nBackground Emerging evidence has demonstrated that lung cancer patients with brain oligometastases (oligo-BMs) could benefit from local radical therapies. Despite rapid advancements in the treatment of oligometastatic disease, the molecular determinants governing the oligometastatic phenotype in the central nervous system remain elusive. Methods We performed 1021-panel sequencing, transcriptome profiling, DNA methylation mapping, and multiplex immunohistochemistry on 20 paired primary lung adenocarcinoma and oligo-BMs specimens to delineate their evolutionary dynamics and microenvironmental characteristics.  \nResults A pronounced intertumor heterogeneity was observed between primary tumors (PTs) and oligo-BMs, while intratumoral heterogeneity was conserved across lesions. Subclonal analysis and phylogenetic reconstruction demonstrated that oligo-BMs exhibited predominant polyclonal seeding patterns and parallel progression trajectories. Moreover, oligo-BMs displayed a more immunosuppressed microenvironment compared to PTs, characterized by attenuated immunogenic cell death signatures, downregulation of immune-activated pathways, and diminished infiltration of activated immune cells (including B cells, NK cells, and Th1 cells) . The methylation levels at functional genomic regions were highly concordant between PTs and oligo-BMs. Notably, we identified NLGN1 as a potential regulator of oligo-BM, where the hypermethylation at its genebody regions was mechanistically associated with transcriptional upregulation. Clinical validation revealed that NLGN1 was specifically overexpressed in BMs  \n†Rongxin Liao, Qian Yu, Yusheng Huang and Yuan Peng contributed equally to this article.  \n*Correspondence:  \nRongrong Zhou [zhourr@csu.edu.cn](zhourr@csu.edu.cn)[ ](zhourr@csu.edu.cn)Zhenzhou Yang [yangzz@cqmu.edu.cn](yangzz@cqmu.edu.cn)  \nYuan Peng [pengyuan1127@cqmu.edu.cn](pengyuan1127@cqmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLiao et al. Genome Medicine (2026) 18:82 Page 2 of 24  \ncompared to PTs and extracranial metastases, correlating with advanced pathological stages and poor prognosis. In vivo studies further confirmed NLGN1 promotes BM in mice.  \nConclusions Our findings pro","cbCaibwYd5qdggn7","https://ap.wps.com/l/cbCaibwYd5qdggn7","pdf",14597802,24,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Background\n## Brain metastasis and oligometastatic disease context","[{\"question\":\"What clinical problem does the study address?\",\"answer\":\"The study addresses how to understand the molecular determinants of the oligometastatic phenotype in the central nervous system, specifically for brain oligometastases in lung adenocarcinoma.\"},{\"question\":\"What data and methods were used to analyze the tumors?\",\"answer\":\"Researchers used 1021-panel sequencing, transcriptome profiling, DNA methylation mapping, and multiplex immunohistochemistry on paired primary and brain oligometastasis specimens.\"},{\"question\":\"What key biological differences were found between primary tumors and oligo-BMs?\",\"answer\":\"Primary tumors and oligo-BMs showed pronounced intertumor heterogeneity, with conserved intratumoral heterogeneity across lesions, alongside a more immunosuppressed microenvironment in oligo-BMs.\"}]","Integrative multi-omics profiling reveals distinct evolutionary and immunogenic features of brain oligometastasis in lung adenocarcinoma | PDF",1790152223,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae0f71893adaf0dab945c31438a190e4.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5bd0673488d8bfb0a912b9b54ffee6e.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce5e6d255af634864abd95ef4678c582.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6583eafbc2b6be5dd9f049e81c881fda.webp",980,1306]